Showing results (51-60 of 94) with videos related to

Sort By:
Pageof 10
Pathology Oncology Research : POR|August 18, 2022
Immunohistochemical Study of the PD-1/PD-L1 Pathway in Cutaneous Lupus ErythematosusZsófia Király, Ágota Szepesi, Anna Sebestyén, et al.
Magyar Onkologia|September 28, 2023
[he importance of mTOR hyperactivity and RICTOR amplification, and the associated targeted therapy possibilities in malignant tumours]Fatime Szalai, Ildikó Krencz, Dorottya Moldvai, et al.
Magyar Onkologia|May 31, 2026
3D bioprinted in vitro models in cancer metabolism researchZsófia Gábriel, Fatime Szalai, Viktória Varga, et al.
Orvosi Hetilap|March 9, 2005
[Soluble syndecan-1 levels in different plasma cell dyscrasias]Judit Jánosi, Anna Sebestyén, Gábor Mikala, et al.
Plos One|May 13, 2022
Survival of HT29 cancer cells is influenced by hepatocyte growth factor receptor inhibition through modulation of self-DNA-triggered TLR9-dependent autophagy responseBettina Bohusné Barta, Ágnes Simon, Lőrinc Nagy, et al.
Hematological Oncology|July 3, 2010
ROR1 expression is not a unique marker of CLLGábor Barna, Rudolf Mihalik, Botond Timár, et al.
Medcomm|June 8, 2026
From 2D to 3D Bioprinted In Vitro Breast Cancer Model: A Comparative Study of Proliferation, Tissue Structure, and mTOR SignalingDorottya Moldvai, Gábor Petővári, Rebeka Gelencsér, et al.
BMC Cancer|May 23, 2013
Characteristic mTOR activity in Hodgkin-lymphomas offers a potential therapeutic target in high risk disease--a combined tissue microarray, in vitro and in vivo studyÁgnes Márk, Melinda Hajdu, Zsófia Váradi, et al.
Bioengineering (Basel, Switzerland)|March 28, 2025
In Vitro Functional and Structural Evaluation of Low-Complexity Artificial Human Epidermis for 3D Tissue EngineeringDorottya Kocsis, Dániel Sztankovics, Liza Józsa, et al.
Neuro-Oncology Advances|July 28, 2025
EZH2 overexpression is associated with aggressive behavior and promotes cell proliferation in CNS WHO grade 3 meningiomasPéter Szőke, Dániel Sztankovics, Titanilla Dankó, et al.
Pageof 10